Acupuncture In Migraine Without Aura Patients
Acupuncture For Preventing Of Attack Frequency And Improving Disability In Migraine Without Aura Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Erzurum, Turkey, 25040
- Rabia Rukiye Akinci
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Being diagnosed with migraine according to IHS (International Headache Association)
- Receiving migraine prophylaxis treatment
- Having more than four attacks per month/more than one attack per week
- Not having received acupuncture treatment before.
Exclusion Criteria:
- Being diagnosed with migraine with aura/secondary headache
- Having received acupuncture treatment for any reason within the last year
- Not giving consent for acupuncture treatment
- Having a fear of needles.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention group
Intervention group will take 12 sessions of acupuncture addition to their prophylaxis treatment.
Acupuncture points will be bilateral LI-4, LI-11, ST-8, ST-44, SP-6, GB-1, GB-14, GB-20, LR-3, and GV-14, GV-20.
Sterile and single-use stainless steel acupuncture needles measuring 0.25x25 mm will be inserted to a depth of 10 mm and be retained for 30 minute without any further stimulation.
Acupuncture will be performed by an acupuncturist with an acupuncture practitioner licence from the Turkish Ministry of Health.
Adverse events will be monitored for all acupuncture sessions.
|
Acupuncture is a complementary therapy modality which is used by needle inserted the specific points on the body.
|
|
No Intervention: Control Group
Control group will take only their migraine prophylaxis treatment.
Participants will followed-up 3 months.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Monthly attack frequency
Time Frame: 3 months
|
The participants will document the each migraine attack days in a month by pain free intervals of at least 48 hours.
|
3 months
|
|
Duration of attacks
Time Frame: 3 months
|
Duration of the each migraine attack as hour
|
3 months
|
|
Pain severity
Time Frame: 3 months
|
Pain severity during migraine attacks will be measured via visual analog scale (VAS).
While 0 indicates no pain, 10 indicates the most severe pain imaginable.
|
3 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disability
Time Frame: 3 months
|
Disability will measured via a questionnaire which is an ordinary rating scale to assess the migraine related disability of a patient with migraine.
Migraine Disability Assessment (MIDAS) will be used.
Migraine Disability Assessment (MIDAS) questionnaire is an ordinary rating scale to assess the migraine related disability of a patient with migraine.
It is based on responses to five questions about disability associated with headache in the last three months.
MIDAS questionnaire has four point grading system.
Scores ranging from 0 to 5 indicates Grade 1 (little or none disability), scores ranging from 6 to 10 indicates Grade 2 (mild disability), scores ranging from 11 to 20 indicates Grade 3 (moderate disability), and scores 21 or greater indicates Grade 4 (severe disability).
|
3 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Yasemin Çayır, Ataturk University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- B.30.2.ATA.0.01.00/113
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.